Found: 81
Select item for more details and to access through your institution.
Preparation and Characterization of BXFO High-Entropy Oxides.
- Published in:
- Magnetochemistry, 2024, v. 10, n. 8, p. 60, doi. 10.3390/magnetochemistry10080060
- By:
- Publication type:
- Article
The nutritional risk in oncology: a study of 1,453 cancer outpatients.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 8, p. 1919, doi. 10.1007/s00520-012-1387-x
- By:
- Publication type:
- Article
Erratum to: The nutritional risk in oncology: a study of 1,453 cancer outpatients.
- Published in:
- 2012
- By:
- Publication type:
- Correction notice
Screening for Frailty in Older Patients With Early-Stage Solid Tumors: A Prospective Longitudinal Evaluation of Three Different Geriatric Tools.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome.
- Published in:
- International Journal of Cancer, 1999, v. 84, n. 3, p. 309, doi. 10.1002/(SICI)1097-0215(19990621)84:3<309::AID-IJC19>3.0.CO;2-3
- By:
- Publication type:
- Article
Further Thoughts on Adjuvant Treatment for Older Breast Cancer Patients.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Reconfigurable Split Ring Resonators by MEMS-Driven Geometrical Tuning.
- Published in:
- Sensors (14248220), 2023, v. 23, n. 3, p. 1382, doi. 10.3390/s23031382
- By:
- Publication type:
- Article
Miniaturized Sensors for Detection of Ethanol in Water Based on Electrical Impedance Spectroscopy and Resonant Perturbation Method—A Comparative Study.
- Published in:
- Sensors (14248220), 2022, v. 22, n. 7, p. 2742, doi. 10.3390/s22072742
- By:
- Publication type:
- Article
Re: Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02-98 Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 2, p. 121, doi. 10.1 093/i nci/djm287
- By:
- Publication type:
- Article
p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.
- Published in:
- International Journal of Oncology, 2018, v. 52, n. 2, p. 424, doi. 10.3892/ijo.2017.4212
- By:
- Publication type:
- Article
Advances in the Development of Innovative Sensor Platforms for Field Analysis.
- Published in:
- Micromachines, 2020, v. 11, n. 5, p. 491, doi. 10.3390/mi11050491
- By:
- Publication type:
- Article
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 2, p. 347, doi. 10.1007/s10549-020-05622-5
- By:
- Publication type:
- Article
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 2, p. 329, doi. 10.1007/s10549-018-4766-2
- By:
- Publication type:
- Article
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 2, p. 351, doi. 10.1007/s10549-018-4767-1
- By:
- Publication type:
- Article
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immune Infiltration in Invasive Lobular Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
RE: Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 1, p. 1, doi. 10.1093/jnci/djt337
- By:
- Publication type:
- Article
Dielectric and Ferroelectric Response of Multiphase Bi‐Fe‐O Ceramics.
- Published in:
- Physica Status Solidi. A: Applications & Materials Science, 2019, v. 216, n. 3, p. N.PAG, doi. 10.1002/pssa.201800584
- By:
- Publication type:
- Article
Treatment of Carcinoid Syndrome with Recombinant Interferon Alpha-2a.
- Published in:
- Acta Oncologica, 1993, v. 32, n. 2, p. 235, doi. 10.3109/02841869309083918
- By:
- Publication type:
- Article
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?
- Published in:
- Ecancermedicalscience, 2013, v. 7, p. 1, doi. 10.3332/ecancer.2013.299
- By:
- Publication type:
- Article
A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 6, p. 703, doi. 10.1007/s12282-019-00973-4
- By:
- Publication type:
- Article
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 4, p. 749, doi. 10.1016/j.molonc.2014.12.001
- By:
- Publication type:
- Article
Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 1, p. 128, doi. 10.1016/j.molonc.2014.07.012
- By:
- Publication type:
- Article
TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 3, p. 508, doi. 10.1016/j.molonc.2013.12.018
- By:
- Publication type:
- Article
Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: A pilot study
- Published in:
- Molecular Oncology, 2012, v. 6, n. 4, p. 437, doi. 10.1016/j.molonc.2012.05.003
- By:
- Publication type:
- Article
DNA Repair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes.
- Published in:
- Oncologist, 2013, v. 18, n. 10, p. 1063, doi. 10.1634/theoncologist.2013-0163
- By:
- Publication type:
- Article
Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institution.
- Published in:
- Breast Journal, 2019, v. 25, n. 6, p. 1225, doi. 10.1111/tbj.13437
- By:
- Publication type:
- Article
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0062543
- By:
- Publication type:
- Article
Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 5, p. 700, doi. 10.1002/cncr.33318
- By:
- Publication type:
- Article
Current Status of HER2 Testing.
- Published in:
- Oncology, 2002, v. 63, p. 25, doi. 10.1159/000066204
- By:
- Publication type:
- Article
The Predictive Value of HER2 in Breast Cancer.
- Published in:
- Oncology, 2001, v. 61, p. 73, doi. 10.1159/000055405
- By:
- Publication type:
- Article
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 12, p. 1677, doi. 10.3390/biom10121677
- By:
- Publication type:
- Article
An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06).
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919891608
- By:
- Publication type:
- Article
Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918815591
- By:
- Publication type:
- Article
The role of abemaciclib in treatment of advanced breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918776925
- By:
- Publication type:
- Article
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 10, p. 2603, doi. 10.1002/cncr.26565
- By:
- Publication type:
- Article
3D Chiral MetaCrystals.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 12, p. 1, doi. 10.1002/adfm.202109258
- By:
- Publication type:
- Article
3D Chiral MetaCrystals.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 12, p. 1, doi. 10.1002/adfm.202109258
- By:
- Publication type:
- Article
Feasibility of evaluating quality cancer care using registry data and electronic health records: a population-based study.
- Published in:
- International Journal for Quality in Health Care, 2012, v. 24, n. 4, p. 411, doi. 10.1093/intqhc/mzs020
- By:
- Publication type:
- Article
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00277-x
- By:
- Publication type:
- Article
Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00222-y
- By:
- Publication type:
- Article
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0123-9
- By:
- Publication type:
- Article
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0097-z
- By:
- Publication type:
- Article
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0094-2
- By:
- Publication type:
- Article
Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2018, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41523-018-0092-4
- By:
- Publication type:
- Article